In this regard, IL-1β has been shown to induce epithelial to mesenchymal transition in breast cancer cells [101] and IL-1 signaling has been related to inflammation and aggressiveness due to the modulation of antitumor immunity in the same type of cancer [102]. The gene discussed is IL1B; the disease is cancer.